BACKGROUND: The protective immune response against Mycobacterium tuberculosis relies both on antigen-presenting cells and on T lymphocytes. In patients with different forms of tuberculosis, varying degrees of T cell function--ranging from positive delayed-type hypersensitivity, in asymptomatic infected healthy individuals, to the absence of the response, in patients with miliary or pulmonary tuberculosis (PTB)--have been reported. The decreased expression of CD3zeta reported in T cells from patients with either cancer or leprosy has provided possible explanations for the altered immune response observed in these diseases. METHODS: The present study aimed to compare the expression of CD3zeta , nuclear transcription factor- kappa B (NF- kappa B), arginase activity, and cytokine production in 20 patients with PTB, in 20 tuberculin-positive asymptomatic subjects, and in 14 tuberculin-negative control subjects. RESULTS: Compared with those in tuberculin (purified protein derivative)-negative control subjects, peripheral-blood T lymphocytes from patients with active PTB had significantly (P < .001) decreased expression of CD3zeta and absence of the p65/p50 heterodimer of NF- kappa B. These alterations were reversed only in patients who responded to treatment. Also reported here for the first time is that the presence of arginase activity in peripheral-blood mononuclear-cell lysates of patients with PTB parallels high production of interleukin-10. CONCLUSIONS: The presence of arginase could, in part, explain the decreased expression of CD3zeta . These findings provide a novel mechanism that may explain the T cell dysfunction observed in patients with PTB.
BACKGROUND: The protective immune response against Mycobacterium tuberculosis relies both on antigen-presenting cells and on T lymphocytes. In patients with different forms of tuberculosis, varying degrees of T cell function--ranging from positive delayed-type hypersensitivity, in asymptomatic infected healthy individuals, to the absence of the response, in patients with miliary or pulmonary tuberculosis (PTB)--have been reported. The decreased expression of CD3zeta reported in T cells from patients with either cancer or leprosy has provided possible explanations for the altered immune response observed in these diseases. METHODS: The present study aimed to compare the expression of CD3zeta , nuclear transcription factor- kappa B (NF- kappa B), arginase activity, and cytokine production in 20 patients with PTB, in 20 tuberculin-positive asymptomatic subjects, and in 14 tuberculin-negative control subjects. RESULTS: Compared with those in tuberculin (purified protein derivative)-negative control subjects, peripheral-blood T lymphocytes from patients with active PTB had significantly (P < .001) decreased expression of CD3zeta and absence of the p65/p50 heterodimer of NF- kappa B. These alterations were reversed only in patients who responded to treatment. Also reported here for the first time is that the presence of arginase activity in peripheral-blood mononuclear-cell lysates of patients with PTB parallels high production of interleukin-10. CONCLUSIONS: The presence of arginase could, in part, explain the decreased expression of CD3zeta . These findings provide a novel mechanism that may explain the T cell dysfunction observed in patients with PTB.
Authors: Tanja Schreiber; Stefan Ehlers; Lisa Heitmann; Alexandra Rausch; Jörg Mages; Peter J Murray; Roland Lang; Christoph Hölscher Journal: J Immunol Date: 2009-06-26 Impact factor: 5.422
Authors: Shannon M Lange; Melanie C McKell; Stephanie M Schmidt; Junfang Zhao; Rebecca R Crowther; Lisa C Green; Rebecca L Bricker; Eusondia Arnett; S Eleonore Köhler; Larry S Schlesinger; Kenneth D R Setchell; Joseph E Qualls Journal: J Immunol Date: 2019-02-01 Impact factor: 5.422
Authors: Zhirong Mou; Helen M Muleme; Dong Liu; Ping Jia; Ifeoma B Okwor; Shiby M Kuriakose; Stephen M Beverley; Jude E Uzonna Journal: J Immunol Date: 2013-03-04 Impact factor: 5.422
Authors: Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman Journal: Semin Immunol Date: 2014-10-11 Impact factor: 11.130
Authors: T E Cloke; L Garvey; B-S Choi; T Abebe; A Hailu; M Hancock; U Kadolsky; C R M Bangham; M Munder; I Müller; G P Taylor; P Kropf Journal: J Infect Dis Date: 2010-08-15 Impact factor: 5.226
Authors: Joshua T Mattila; Olabisi O Ojo; Diane Kepka-Lenhart; Simeone Marino; Jin Hee Kim; Seok Yong Eum; Laura E Via; Clifton E Barry; Edwin Klein; Denise E Kirschner; Sidney M Morris; Philana Ling Lin; Joanne L Flynn Journal: J Immunol Date: 2013-06-07 Impact factor: 5.422
Authors: Manuel Modolell; Beak-San Choi; Robert O Ryan; Maggie Hancock; Richard G Titus; Tamrat Abebe; Asrat Hailu; Ingrid Müller; Matthew E Rogers; Charles R M Bangham; Markus Munder; Pascale Kropf Journal: PLoS Negl Trop Dis Date: 2009-07-14